Thiruvananthapuram, April 25 (IANS) The Indian Space Research Organisation (ISRO), Department of Space (DoS), and Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), under the Department of Science and Technology (DST), have signed a Framework Memorandum of Understanding on Cooperation in Space Medicine.
This partnership marks a significant milestone in advancing the field of space medicine and its applications in India.
ISRO’s human spaceflight programme, Gaganyaan, is a national endeavour that opens up unique opportunities for collaboration with academic institutions, national agencies, and industries in areas such as human health research, microgravity studies, space biology, and space medicine.
The MoU is expected to catalyse cooperation in this niche area and support innovations in several critical domains, including human physiological and behavioural studies, biomedical support systems, radiation biology, countermeasures for maintaining health and performance in space, telemedicine protocols, and the development of crew medical kits for space missions.
The programme will also create opportunities for cutting-edge research and experiments in space medicine, with potential benefits extending beyond space missions to healthcare on Earth.
Dr V. Narayanan, Chairman, ISRO, Secretary, DoS and Chairman, Space Commission, said the Gaganyaan mission aims to build national capacity in human research under space conditions. He emphasised the importance of maintaining astronaut health and performance in the extreme environment of outer space for the success of long-duration missions.
He noted that a national platform like the Bharatiya Antariksh Station would further enable advanced human research and technology development aligned with India’s priorities.
Dr Kris Gopalakrishnan expressed hope that the initiative would foster strong collaboration between academia and industry in the development of innovative medical devices.
Dr Sunil Kumar, Additional Secretary and Head, AI Division, DST, said that research in space medicine will enhance understanding of human physiology and adaptation, and lead to the development of new medical technologies and diagnostic procedures.
Dr Sanjay Behari, Director, SCTIMST, thanked the ISRO leadership and said the institute looks forward to a productive partnership. He noted plans for setting up clean rooms and microgravity labs, joint development of biomedical devices, and translating space-grade technologies for terrestrial healthcare.
SCTIMST, a premier medical research institute and an Institute of National Importance under DST, focuses on advanced medical research and healthcare services, particularly in the fields of cardiac and neurosciences.
–IANS
sg/skp
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
